News for Haematology and Stem Cells

Eight BRC projects get RCF funding

7 September 2020 · Listed under Cardiovascular, Clinical Informatics and Big Data, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Genomic Medicine, Haematology and Stem Cells, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies, Multimorbidity and Long-Term Conditions, Neurological Conditions, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Technology and Digital Health

Eight Oxford BRC proposals, many covering a number of themes, have been awarded NIHR Research Capability Funding (RCF) funding to take forward key areas of research. The selected projects that will be supported include: Developing a research centre devoted to urgent and acute care The creation of a state-of-the-art imaging centre; and of a new … Read more

Test developed to identify new-borns at risk of leukaemia

21 August 2020 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Oxford researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe. Until now, the only reliable way to know if a baby with Down’s syndrome is at risk of … Read more

Serum iron may be useful biomarker to identify COVID-19 disease severity

15 June 2020 · Listed under COVID-19, Haematology and Stem Cells

A new study led by University of Oxford researchers has found that patients with severe COVID-19 respiratory failure have very low levels of iron, compared to those with less severe disease. Changes in iron levels have been associated with worsening disease for other viral infections such as HIV and Hepatitis C, but this is the … Read more

BRC funds three further COVID-19 studies

21 April 2020 · Listed under COVID-19, Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Vaccines for Emerging and Endemic Diseases

Three more studies are being funded by the NIHR Oxford Biomedical Research Centre (BRC) to look at the way the body interacts with COVID19; these include assessing the safety of a new vaccine; the role that antibodies might play in plasma therapy; and blood biomarkers that determine adverse reactions in those that have been infected. … Read more

Seven new Senior Fellows named

2 April 2020 · Listed under Haematology and Stem Cells, Multi-Modal Cancer Therapies, Neurological Conditions, Other News

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows, the second cohort of emerging research leaders to receive the accolade. The selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR Oxford Health BRC, which focuses on mental health and dementia, and the … Read more

Oxford haematologists win national awards to further their research

13 September 2019 · Listed under Cardiovascular, Haematology and Stem Cells

Two consultant haematologists at the Oxford Haemophilia and Thrombosis Centre (OHTC), based at the Churchill Hospital, have been awarded funding for their research as part of a new national scheme. Dr Nicola Curry and Dr Susie Shapiro were among the recipients of the new Clinical Academic Research Partnerships (CARPs), awarded by the Medical Research Council … Read more

Study discovers genetic changes linked to leukaemia in children with Down’s syndrome

11 July 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Researchers at the University of Oxford have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome. Children with Down’s syndrome have a 150-fold increased risk of myeloid leukaemia, and while some of the genetic causes of this have been previously established, this is the first study … Read more

Oxford Blood Group: Exchange Newsletter Issue 3 vol 1 / June 2019

9 July 2019 · Listed under Oxford Blood Group

Patient involvement partnership sets priorities for rare inherited anaemias

28 February 2019 · Listed under Haematology and Stem Cells, Oxford Blood Group, Partnerships for Health, Wealth and Innovation

On the occasion of Rare Diseases Day, marked every year on the last day of February, we are sharing this article about how patients, carers, clinicians and researchers are collaborating to decide key questions to shape future research into rare forms of anaemia. Patients with anaemia lack red blood cells, or haemoglobin, which means that … Read more

Oxford researchers develop new technique to analyse cancer cells’ life history

11 February 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

A team of researchers from the University of Oxford has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find out how these might lead to uncontrollable growth. The research by the MRC Weatherall Institute of Molecular Medicine, supported by the NIHR Oxford Biomedical Research Centre, could … Read more

Oxford Blood Group: Exchange Newsletter Issue 1 vol 2 / Nov 2018

26 November 2018 · Listed under Oxford Blood Group

Researchers map leukaemia ‘family trees’ in patients treated with new drug

24 July 2018 · Listed under Haematology and Stem Cells

A team of international researchers, including experts from NIHR Oxford BRC, has for the first time mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient stops responding to the treatment, providing … Read more

New haematology patient group launched

1 June 2018 · Listed under Haematology and Stem Cells, Partnerships for Health, Wealth and Innovation

The launch of a new patient engagement group for those with blood conditions has brought together patients, clinicians and researchers to discuss how to get patient involved in research. A screening of the film People are Messy at the Ultimate Picture Palace followed by a group discussion marked the launch of the Oxford Blood Group, a new local … Read more

Oxford Centre for Haematology stages inaugural event

26 March 2018 · Listed under Haematology and Stem Cells

The new Oxford Centre for Haematology has held its inaugural event at Keble College, Oxford. The event, which will be held annually, was attended by around 200 academics, healthcare professionals and representatives of industry. Some speakers travelled from as far away as the United States. The event was opened by Prof Paresh Vyas, Director of … Read more

Oxford medical researchers win prestigious national awards

23 February 2018 · Listed under Antimicrobial Resistance and Modernising Microbiology, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Obesity, Diet and Lifestyle, Partnerships for Health, Wealth and Innovation, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Vaccines for Emerging and Endemic Diseases

Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more

Oxford Centre for Haematology launched

10 January 2018 · Listed under Haematology and Stem Cells

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxford University Hospitals NHS Foundation Trust. The aim of this new virtual centre is to bring people working in haematology together to improve the understanding and treatment … Read more

MDS Patient Support Group learn more about treatment of condition

13 October 2017 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition. The members of the Oxford and Thames Valley MDS Patient Support Group visited the WIMM Friday 29 September. MDS are a group … Read more

Researchers thank Bloodwise fundraisers for funding critical leukaemia trial

11 October 2017 · Listed under Haematology and Stem Cells, Other News

Staff and patients at the Oxford Cancer Centre at the Churchill Hospital have thanked fundraisers for the Bloodwise charity who have raised enough money to fully fund a trial of a new leukaemia drug. The staff and patient Thelma, who has been on the trial, sent their appreciation in a video to Bloodwise after fundraisers, … Read more

New drug gives hope in fight against leukaemia

21 September 2017 · Listed under Haematology and Stem Cells

An international group of haematology scientists, including leading researchers in Oxford, have secured approval from the US Food and drug Administration (FDA) for a new leukaemia drug that has produced exciting results in clinical trials. The development of Enasidenib has given hope to people with a form of acute myeloid leukaemia (AML), one of the … Read more

New clinical trial to tackle hard-to-treat leukaemia

2 December 2015 · Listed under Haematology and Stem Cells, Multi-Modal Cancer Therapies

A new clinical trial at Oxford’s Churchill Hospital plans to study the safety of a new experimental drug to treat a form of leukaemia, called Acute Myeloid Leukaemia (AML). Acute myeloid leukaemia is the most common aggressive blood cancer and there are about 2,200 new cases in the UK each year. It can be hard … Read more

OUR 20 RESEARCH THEMES